Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array solutions to fuel genomic discoveries
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Dante Genomics biotech, deeptech, Biotechnology Research | Other 22 Feb 2024 | | ||
ARGALY greentech, cleantech, Biotechnology Research | Other 4 Jun 2024 | | ||
French National Rare Disease Registry healthtech | Other 30 Nov 2023 | | ||
OrphanDev deeptech | Other 30 Nov 2023 | | ||
Jiva.ai it services, Software Development | Other 11 Jan 2024 | | ||
Zion Market ResearchTM Market Research | Other 31 Oct 2023 | | ||
Impartner Software it services, Software Development | Other 17 Jan 2024 | | ||
Samen voor Eindhoven civictech, Civic and Social Organizations | Other 14 Mar 2024 | | ||
Medical Product Outsourcing Media Production | Other 19 Dec 2023 | | ||
Turing Biosystems biotech, healthtech | Other 30 Sep 2023 | |